All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
05/15/20	4	Statement of changes in beneficial ownership of securities	2
05/13/20	4	Statement of changes in beneficial ownership of securities	2
05/07/20	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	45
04/28/20	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	3
04/28/20	DEF 14A	Definitive proxy statements	38
04/17/20	4	Statement of changes in beneficial ownership of securities	2
04/02/20	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents EX-99.1	11
03/06/20	424B5	Prospectus filed pursuant to Rule 424(b)(5)	21
03/05/20	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5.1 EX-23.2	7
03/05/20	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-4.1 EX-10.14 EX-10.21 EX-10.22 EX-23.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	249